original ) (raw )Tracking progress: an update on animal models for Duchenne muscular dystrophy
Dominic Wells
Disease Models & Mechanisms, 2018
View PDFchevron_right
The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy
Dominic Wells
Wellcome open research, 2022
View PDFchevron_right
Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
Sara De Palma
Journal of Cachexia, Sarcopenia and Muscle, 2020
View PDFchevron_right
Lifelong Physical Activity Modulation of the Skeletal Muscle Mitochondrial Proteome in Mice
Rui Vitorino
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2010
View PDFchevron_right
A brief history of muscular dystrophy research: A personal perspective
Byron A Kakulas
Neurology India, 2008
View PDFchevron_right
Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches
Shin'Ichi Takeda
Journal of Personalized Medicine, 2019
View PDFchevron_right
Advances and perspectives in muscular dystrophies
Corrado Angelini
View PDFchevron_right
Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds
Tania Fiaschi
Journal of proteomics, 2017
View PDFchevron_right
The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy
Elisabeth Barton
Scientific Reports, 2020
View PDFchevron_right
Dystropathology Increases Energy Expenditure and Protein Turnover in the Mdx Mouse Model of Duchenne Muscular Dystrophy
Elizabeth Atahan , Horacio Sosa , Marta Fiorotto
PLoS ONE, 2014
View PDFchevron_right
Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy
Ada Massari , A. Giustino
Human Molecular Genetics, 2014
View PDFchevron_right
Exercise and duchenne muscular dystrophy: Where we have been and where we need to go
Laura Case
Muscle & Nerve, 2012
View PDFchevron_right
P.318MRI evaluation of skeletal muscle in the deltaE50-MD dog model of Duchenne muscular dystrophy
Dominic Wells
Neuromuscular Disorders, 2019
View PDFchevron_right
Exercise exacerbates decline in the musculature of an animal model of Duchenne muscular dystrophy
Dana Niswonger
2018
View PDFchevron_right
Taurine enhances skeletal muscle mitochondrial function in a rat model of resistance training
Omid Farshad
PharmaNutrition, 2019
View PDFchevron_right
Drugs in development and dietary approach for Duchenne muscular dystrophy
Corrado Angelini
Orphan Drugs: Research and Reviews, 2015
View PDFchevron_right
Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy
Youssef Hibaoui
Journal of Pineal Research, 2011
View PDFchevron_right
The role of individual protein turnover in skeletal muscle adaptation
Stuart Hesketh
2020
View PDFchevron_right
Effects of Low-Intensity and Long-Term Aerobic Exercise on the Psoas Muscle of mdx Mice: An Experimental Model of Duchenne Muscular Dystrophy
Maria Paula Guerreiro
International Journal of Molecular Sciences
View PDFchevron_right
Physical exertion exacerbates decline in the musculature of an animal model of Duchenne muscular dystrophy
Andrés Vidal-Gadea
Proceedings of the National Academy of Sciences, 2019
View PDFchevron_right
Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests
linda lowes
Pediatric Neurology, 2020
View PDFchevron_right
Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy
Claes Wahlestedt
The FASEB Journal, 2005
View PDFchevron_right
Report on the Second Endocrine Aspects Of Duchenne Muscular Dystrophy Conference December 1-2, 2010, Baltimore, Maryland, USA
Emily Germain-Lee
Neuromuscular disorders : NMD, 2011
View PDFchevron_right
Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the mdx Mouse Model of Duchenne Muscular Dystrophy
Alfredo Guerron
PLoS ONE, 2010
View PDFchevron_right
Physiological Characterization of Muscle Strength With Variable Levels of Dystrophin Restoration in mdx Mice Following Local Antisense Therapy
Dominic Wells
Molecular Therapy, 2011
View PDFchevron_right
Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients
Eric Hoffman
View PDFchevron_right
Immunophenotype of a Rat Model of Duchenne's Disease and Demonstration of Improved Muscle Strength After Anti-CD45RC Antibody Treatment
Alexis Chenouard
Frontiers in Immunology, 2019
View PDFchevron_right
Myostatin/activin blocking combined with exercise reconditions skeletal muscle expression profile of mdx mice
Urho Kujala
Molecular and Cellular Endocrinology, 2015
View PDFchevron_right
Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy
V. Sblendorio
Neuropathology and Applied Neurobiology, 2011
View PDFchevron_right
Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients
U. Ruegg
Journal of Neuromuscular Diseases, 2015
View PDFchevron_right
Duchenne muscular dystrophy
Nathalie Goemans
Nature Reviews Disease Primers, 2021
View PDFchevron_right
Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle
Jacques S Beckmann
The Journal of Physiology, 2002
View PDFchevron_right
Fatigue in young people with Duchenne muscular dystrophy
Kathy Speechley
Developmental Medicine & Child Neurology, 2019
View PDFchevron_right